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BACKGROUND: Early fluid and electrolyte imbalances may be associated with an increased risk of bronchopulmonary dysplasia. 
OBJECTIVE: We sought to establish an association between fluid and electrolyte balance in the first week of life and the risk of 
bronchopulmonary dysplasia.
METHODS: Clinical charts of 205 neonates <32 weeks gestational age and/or <1,250 g birth weight (admitted to our NICU be-
tween 1997 and 2008) were analyzed. Clinical features, fluid and electrolyte balance were analyzed for the first 7 days of life using 
multivariate models of generalized estimation equations. A p value <0.05 was considered significant in all of the hypothesis tests.
RESULTS: The prevalence of bronchopulmonary dysplasia was 22%. Lower gestational age and birth weight, male gender, less 
frequent use of antenatal steroids, respiratory distress syndrome, use of surfactant, patent ductus arteriosus, duration of invasive 
ventilation and NICU stay were significantly associated with bronchopulmonary dysplasia. The variation in serum values of potas-
sium, phosphorus and creatinine during the first week of life also revealed an association with bronchopulmonary dysplasia. Higher 
mean plasma calcium values were associated with spontaneous closure of the patent ductus arteriosus. The use of indomethacin to 
induce patent ductus arteriosus closure was significantly higher in bronchopulmonary dysplasia patients. 
CONCLUSIONS: Differences in renal function and tubular handling of potassium and phosphorus are present during the first 
week of life among preterm neonates who will develop bronchopulmonary dysplasia. The higher rate of patent ductus arteriosus 
and indomethacin use may influence these differences. Serum levels of calcium also appear to play a role in spontaneous ductus 
arteriosus closure. 
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INTRODUCTION
Low gestational age and birth weight are among the 
many known etiologic factors for the development of 
bronchopulmonary dysplasia (BPD). One of the first 
retrospective reviews on fluid balance1 demonstrated that 
compared to control infants, infants with BPD received greater 
quantities of total, crystalloid and colloid fluids per kilogram 
of body weight in the first days of life. Another retrospective 
analysis of a cohort of 1,382 extremely low birth weight 
infants performed by Oh et al.2 concluded that higher fluid 
intake and reduced weight loss during the first 10 days of 
life are associated with an increased risk of BPD. Bell and 
Acarregui3 examined the effect of water intake on postnatal 
weight loss and the risk of neonatal morbidity. They found 
that restricted water intake significantly increases postnatal 
weight loss and significantly reduces the risk of patent ductus 
arteriosus and necrotizing enterocolitis. They also found a 
trend toward a reduced risk of BPD, intracranial hemorrhage 
and death. Preterm neonates with delayed diuresis appear 
to be at a significantly greater risk of BPD.4. Costarino et 
al.5 demonstrated that withholding sodium supplementation 
during the first 3-5 days of life reduces BPD. In that study, 
care givers tended to prescribe daily increases in parenteral 
fluids for the salt-supplemented infants, perhaps because 
serum sodium concentrations were elevated after the first 
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days of the study. There is also some evidence for magnesium 
imbalances in the pathogenesis of BPD.6,7
These findings suggest that careful attention to fluid and 
electrolyte balance may be an important means to reduce the 
incidence of BPD.
Here, we reviewed the clinical data from the first week 
of life of preterm neonates admitted to our center during a 
12-year period establish an association between fluid and 
electrolyte balance and the risk of BPD.
MATERIALS AND METHODS
Preterm neonates <32 weeks of gestational age and/
or <1,250 g birth weight (admitted between January 1997 
and December 2008) were identified from the database 
of our neonatal intensive care unit (NICU), a tertiary 
center. Preterm neonates affected by a TORCH infection, 
a chromosomal or major congenital anomaly, twin-twin 
transfusion syndrome, asphyxia, and any inborn error of 
metabolism detected during the neonatal period, as well as 
those infants who were admitted after day 2 of life or died 
before 36 weeks corrected age, were excluded.
Clinical features, including gender, gestational age, 
birth weight, antenatal steroid pulses, mode of delivery, 
histological chorioamnionitis, neonatal morbidity, use 
of exogenous surfactant, oxygen therapy, mechanical 
ventilation, daily weight and urine output, fluid and 
electrolyte balance, hematocrit and need for blood 
transfusions during the first 7 days of life, were collected 
from hospital charts. 
The study protocol was approved by the institute’s 
committee on human research.
Standard care
Until 2003, the antenatal steroid regimen included 
dexamethasone (total dose of 24 mg, divided into two doses 
given intramuscularly every 12 h). Thereafter, treatment 
consisted of betamethasone (24 mg, divided into two doses 
given intramuscularly 24 h apart) in pregnancies at risk of 
preterm labor prior to 35 weeks gestation.
All infants received standard management in the NICU, 
including an incubator humidity of 80-85% in the first week 
of life. Neutral thermal environmental temperatures in 
range of 34.0-35.4 ºC were maintained to keep the infant’s 
temperature between 36.0-37.0 ºC. Fluid and electrolyte 
management in the first day of life included 70-80 ml/kg 
10% dextrose in water supplemented with 10% calcium 
gluconate (2 ml/kg/day before 2007 and 4-6 ml/kg/day 
after 2007). When possible, parenteral and enteral nutrition 
were initiated on the second day of life. Parenteral nutrition 
supplemented with 0.5 g/kg/day protein, with daily increments 
of 0.5 g/kg/day to a final level of 3 g/kg/day was used prior to 
2003. In 2003, we began to use a parenteral nutrition regimen 
containing 1 g/kg/day of protein, with daily increments of 
1 g/kg/day up to 3.5 g/kg/day. Parenteral nutrition was also 
supplemented with sodium (2 mEq/kg/day, as 20% sodium 
chloride or glycerophosphate), potassium (2 mEq/kg/day, 
as 7.5% potassium chloride), calcium (20-60 mg/kg/day, as 
10% calcium gluconate), magnesium (0.3-0.4 mEq/kg/day, as 
20% magnesium sulfate) and phosphorus (1 mmol/kg/day, as 
glycerophosphate). Phosphorus supplementation with sodium 
glycerophosphate (Glycophos®) contains 2 mEq of sodium per 
milliliter, which was considered as the total amount of daily 
sodium supplementation. When possible, lipids were infused 
beginning on the second day of life. Lipid concentrations 
started at 0.5 g/kg/day with daily increments of 0.5 g/kg/
day up to 3.0 g/kg/day before 2003 and at 1.0 g/kg/day with 
daily increment of 1.0 g/kg/day until 3.0 g/kg/day thereafter. 
Enteral feeding was usually initiated on the second day of life 
using either mother’s milk or preterm formula, according to 
the infant’s clinical condition. The infant received 1 ml every 
3 h, with daily increments according to enteral tolerance 
and clinical condition. Total fluid administration (parenteral 
and enteral) started at 70-80 ml/kg/day, with increments of 
10-15 ml/kg/day until 150 ml/kg/day was reached by day 
7 of life and maintained until 3 weeks of age. The fluid 
volume was increased in 10 ml/kg/day increments in infants 
undergoing phototherapy. Fluid and electrolyte replacement 
therapy were monitored by daily weight measurements, vital 
signs determinations, urine output and serum laboratory 
studies. Glucose and electrolytes were maintained within 
the normal range: 40-150 mg/dl glucose; 135-145 mEq/L 
sodium; 98-108 mEq/L chloride; 4-6 mEq/L potassium; 
4.4-5.4 mg/dl calcium; 1.5-2.3 mEq/L magnesium; 30-90 
mg/L phosphorus. Blood pressure should be at least the same 
number as gestational age in weeks, and urine output should 
be between 1-5 ml/kg/h.8 Plasma osmolality was considered 
normal when values were between 275-290 mOsm/L. The 
blood transfusion practice was used according to the criteria of 
Simon et al. 9. 
Definitions
The diagnosis of BPD was made if the infant was 
chronically oxygen dependent at 36 weeks of corrected age 
and had a characteristic chest radiograph.10 Gestational age 
(in this study, we considered the completed weeks) was 
assessed by menstrual age (women with regular menstrual 
cycles), ultrasound examination (when a discrepancy of 
two or more weeks existed between the age derived by 
menstrual dating and the age derived sonographically, or 
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in the absence of a menstrual date)11 or the New Ballard 
Score (in the absence of obstetrical indexes).12 Intrauterine 
growth restriction was defined as a birth weight below the 
10th percentile on Fenton’s fetal growth charts.13 Histological 
chorioamnionitis was classified according to the method 
proposed by Blanc.14 All grades of chorioamnionitis were 
grouped together. Respiratory distress syndrome (hyaline 
membrane disease) was defined according to the criteria 
of Rudolf et al.15 Proven neonatal sepsis was defined as 
any systemic bacterial or fungal infection documented 
by a positive blood culture. Hemodynamically significant 
patent ductus arteriosus was diagnosed on the basis of 
the echocardiographic findings. The first evaluation is 
usually between 24 and 72 h of life, with daily evaluation 
until closure of the ductus. The standard treatment for 
patent ductus arteriosus is indomethacin. The criteria 
of Bell were used for the diagnosis and staging of 
necrotizing enterocolitis.16 Retinopathy of prematurity was 
staged according to the international classification.17,18 
Intraventricular hemorrhage was classified according 
to Papile.19 Periventicular leukomalacia was classified 
according to de Vries and Rennie.20
Fluid and electrolyte balance evaluation
Fluid, plasma glucose, electrolyte balance (sodium, 
chloride, potassium, magnesium, calcium, and phosphorus), 
urea nitrogen, creatinine, osmolality, hematocrit, need for 
blood transfusions, daily urine output and weight were 
analyzed for the first 7 days of life. Sodium, potassium, 
chloride, calcium and hematocrit were evaluated daily 
along with acid-base status during the first week of life 
or while on respiratory support. Glycemia, evaluated by 
Dextrostix or Chemstrip-bG testing, was determined every 
6-8 h, or at different time intervals according to either the 
previous determination or clinical condition. Plasma glucose, 
magnesium, phosphorus, urea nitrogen and creatinine, as 
well as ionogram and calcium, are routinely evaluated on 
the second day of life and at 1-3-day intervals thereafter 
during the first week of life, according to the infant’s clinical 
condition. For all of these parameters except glucose, 
an average value of two consecutive determinations was 
used to calculate an approximate daily balance. Plasma 
osmolality was estimated based on the following formula: 
osmolality (mOsm/L) = 2 x [plasma sodium (mEq/L)] 
+ [plasma glucose (mg/dl)] / 18 + [blood urea nitrogen 
(mg/dl)] / 2.8. (Note: this estimated osmolality is usually 
slightly lower than the measured osmolality; we considered 
estimated values of 275-290 mOsm/L as normal, which 
is slightly lower than the normal measured values of 
285-295 mOsm/L).
Fluid and electrolyte balance, daily plasma osmolality, 
weight, urine output, hematocrit and need for blood 
transfusions were compared between preterm neonates who 
developed BPD and those who did not develop this condition. 
Statistics
The appropriate summary statistics were applied to 
describe the analyzed samples. Categorical variables were 
described using absolute and relative (%) frequencies. 
Continuous variables were described using either means and 
standard deviations or medians, percentile 25 and percentile 
75, depending on their symmetrical or asymmetrical 
distribution, respectively. To assess the association between 
categorical variables, we used the chi-squared test or 
Fischer’s exact test. The Student’s t-test or the respective 
nonparametric Mann-Whitney U test was used to compare 
two independent samples. To assess the risk factors 
associated with the outcomes of BPD and patent ductus 
arteriosus, odds ratios (ORs) and the respective 95% 
confidence intervals were calculated through logistic 
regression. To assess renal function and the 7-day fluid and 
electrolyte longitudinal variation, multivariate models of 
generalized estimation equations (GEEs) were used.
 A p value <0.05 was considered significant in all of the 
hypothesis tests. The analyses were done using SPSS v. 15.0 
for Windows.
RESULTS
Demographic and clinical characteristics
Of 440 preterm neonates, 205 were included in this study. 
The prevalence of BPD was 22% (n = 45). Demographics and 
clinical characteristics of the studied sample are reported in 
Tables 1 and 2. Younger gestational age, lower birth weight, 
male gender and less frequent use of antenatal steroids were 
associated was BPD (Table 1). The association between 
respiratory distress syndrome, use of surfactant, duration 
of invasive ventilation, patent ductus arteriosus, duration 
of NICU stay and BPD was statistically significant after 
adjustments for gender, gestational age, birth weight and 
antenatal steroids use (Table 2). There was no difference in 
BPD prevalence between two time periods in which different 
guidelines for antenatal steroids and parenteral nutrition was 
used (1997-2002 and 2003-2008) (Table 3).
Multivariate model of GEE of fluid and electrolyte 
longitudinal variation
The values from the first evaluation of the studied 
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Table 1 - Demographics of the studied population (n=205).
Total
n=205
BPD absent
n=160 
(78%)
BPD present
n=45 
(22%)
p OR(1) 95% CI OR(2) 95% CI
Birth weight (g), mean (sd) 1007 (219) 1041 (218) 886 (175) <0.001‡ 0.996 0.994 0.998 - - -
Gestational age (weeks), 
mean (sd)
29 (2) 29 (2) 27 (2) <0.001‡ 0.580 0.468 0.719 - - -
Female, n (%) 99 (48) 87 (54) 12 (27) 0.001* 1.000 - - - - -
Male, n (%) 106 (52) 73 (46) 33 (73) - 3.277 1.579 6.803 - - -
IUGR, n (%) 53 (26) 44 (28) 9 (20) 0.310* 0.659 0.294 1.480 0.611 0.147 2.545
Antenatal steroids, n (%) 179 (87) 144 (90) 35 (78) 0.030* 0.389 0.163 0.930 - - -
full cycle, n (%) 136 (66) 111 (69) 25 (56) 0.083* 0.552 0.280 1.086 0.939 0.388 2.275
C-section, n (%) 146 (71) 117 (73) 29 (64) 0.256* 0.666 0.330 1.346 1.366 0.541 3.452
IUGR, intrauterine growth restriction; sd, standard deviation; * Chi-squared test; ‡ student’s t-test; (1) simple odds ratio (OR); (2) adjusted OR to the 
variables birth weight (g), gestational age (weeks), gender and antenatal steroids; CI, confidence interval
Table 2 - Clinical characteristics of the studied population (n=205).
Total
n=205
BPD absent
n=160 
(78%)
BPD present
n=45 
(22%)
p OR(1) 95% CI OR(2) 95% CI
Histological chorioamnionitis, 
n (%)
75 (37) 51 (32) 24 (53) 0.008* 2.443 1.246 4.790 1.965 0.807 4.785
RDS, n (%) 144 (70) 102 (64) 42 (93) <..001* 7.961 2.362 26.826 4.214 1.170 15.181
Surfactant, n (%) 126 (61) 85 (53) 41 (91) <.001* 9.044 3.094 26.436 5.140 1.661 15.902
Ventilation (ETT), n (%) 167 (81) 123 (77) 44 (98) 0.001* 13.236 1.763 99.366 4.424 0.541 36.152
Days of ventilation (ETT), 
median (P25-P75)
5 (1 - 21) 3 (1 - 11) 40 (25- 63) <0.001* 1.100 1.069 1.131 1.093 1.057 1.129
NCPAP, n (%) 182 (89) 142 (89) 40 (89) 0.979* 1.014 0.354 2.901 0.307 0.086 1.098
Days of NCPAP, median (P25-
P75)
18 (5 - 31) 16 (4 - 30) 25 (10 - 38) 0.014§ 1.029 1.010 1.049 1.010 0.988 1.033
Oxygen, n (%) 181 (88) 136 (85) 45 (100) 0.006* - - - - -
Days of oxygen, median 
(P25-P75)
12 (1 - 52) 4 (1 - 27) 84 (70 - 112) <0.001§ 1.273 1.133 1.430 - - -
PDA, n (%) 56 (27) 31 (19) 25 (56) <0.001* 5.202 2.566 10.545 4.302 1.809 10.231
Nosocomial sepsis, n (%) 123 (60) 86 (54) 37 (82) <0.001* 3.980 1.744 9.081 2.401 0.965 5.974
NEC ≥ 2A, n (%) 10 (5) 5 (3) 5 (11) 0.043** 3.875 1.069 14.041 2.491 0.569 10.909
IVH (grades III-IV), n (%) 17 (8) 7 (4) 10 (22) 0.001** 6.245 2.222 17.551 2.647 0.816 8.581
PVL, n (%) 9 (4) 3 (2) 6 (13) 0.004** 8.051 1.928 33.630 3.552 0.666 18.938
ROP > 2, n (%) 13 (6) 6 (4) 7 (16) 0.009** 1.076 0.497 2.329 0.693 0.283 1.695
NICU stay (days), median 
(P25-P75)
64 (51 - 80) 60 (48 - 70) 88 (73 - 105) <0.001§ 1.080 1.053 1.107 1.071 1.041 1.102
Deceased > 36 weeks, n (%) 6 (3) 0 (0) 6 (13) <0.001** - - - - -
ETT, endotracheal tube; NCPAP, nasal continuous positive airway pressure; NICU, neonatal intensive care unit; NEC, necrotizing enterocolitis; P, 
percentile; PDA, patent ductus arteriosus; PVL, periventricular leukomalacia; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity; sd, 
standard deviation; * Chi-squared test; ** Fisher’s exact test; § Mann-Whitney U test; (1) simple odds ratio (OR); (2) adjusted OR to the variables birth 
weight (g), gestational age (weeks), gender and antenatal steroids; CI, confidence interval
Table 3 - Incidence of BPD during two different treatment periods (n=205).
1997-2002
(n=118) (58%)
2003-2008
(n=87) (42%)
p
Birth weight (g), median (P25-P75) 990 (875-1,123) 1,040 (860-1,185) 0.247§
Gestational age (weeks), mean (sd) 28 (2) 29 (2) 0.353‡
BPD
Absent 90 (76) 70 (81) 0.474*
Present 28 (24) 17 (19)
sd, standard deviation; P, percentile; * Chi-squared test; ‡ Student’s t-test; § Mann-Whitney U test
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parameters are reported in Table 4. On the first or second 
day of life, serum glucose and phosphorus were higher in 
BPD patients and serum calcium, creatinine and hematocrit 
were lower in these patients compared to neonates without 
BPD. A multivariate model of GEE of the longitudinal 
variation (from the first or second to the seventh day of 
life) of total fluids, glucose, electrolytes, urea, creatinine, 
osmolality, diuresis and weight is reported in Tables 5 
and 6. Gestational age (β2 coefficient, Table 5) had a 
significant effect on all parameters except total fluids, 
sodium and chloride. An increase of 1 week in gestational 
age (including all neonates in the study) gave rise to 
a decrease in serum values of potassium, magnesium, 
phosphorus, urea, creatinine, glucose, osmolality and 
diuresis and increased calcium serum values, hematocrit 
and weight. The daily variation (coefficient β3, Table 
5) from the first or second day of life to the seventh day 
of life was significant in all of the analyzed parameters 
except potassium, magnesium and urea. Total fluids, serum 
calcium and diuresis increased from the first to the seventh 
day of life (including all neonates of the study). The other 
analyzed parameters decreased from the first or second 
day of life to the seventh. None of the analyzed parameters 
showed significant variation in patients who developed 
BPD (coefficient β4, Table 5). Calcium supplementation 
of 40-60 mg/kg/day (versus 20-30 mg/kg/day used as a 
reference value) gave rise to an increase in serum calcium 
from the first to the seventh day of life (β6, Table 6). 
Supplementing with phosphate (phosphorus 1-2 mmol/
kg/day), however, decreased the phosphorus serum values 
from the second to the seventh day of life (β6, Table 6). 
Phosphorus presented two interactions in this GEE model: 
one related to the clinical intervention (supplementation 
with phosphate) and another related to BPD (Table 6). 
Both the clinical intervention with phosphorus (phosphate 
supplementation) and developing BPD were associated 
with a decrease in serum values of phosphorus from the 
second to the seventh day of life.
The variation in serum values of potassium, phosphorus 
and creatinine (β7, Table 6) during the first week of life 
revealed an association with BPD. A daily decrease in serum 
levels of potassium and phosphorus and a daily increase in 
serum creatinine were observed. Although these parameters 
(potassium, phosphorus and creatinine) were not associated 
with BPD when evaluated as one isolated day value (β4, 
Table 5), their serum level variation during the first 7 days 
of life revealed a statistically significant association with 
developing BPD (β7 and β8, Table 6).
Table 4 - Clinical parameters obtained on the first or second day of life.
Total
n = 205
BPD absent
n = 160 (78%)
BPD present
n = 45 (22%) p
Total fluids, day 1 (mlkg/day)
median (P25-P75) 90 (80-100) 90 (80-100) 90 (90-100) 0.081§
Glucose, day 1 (mg/dl)
median (P25-P75) 100 (80-120) 95 (80-110) 110 (94-121) 0.012§
Sodium, day 1 (mEq/l) 
mean (sd) 138.75 (5.71) 139.01 (5.96) 137.84 (4.66) 0.229‡
Chloride, day 1 (mEq/l)
mean (sd) 107.07 (5.57) 107.29 (5.58) 106.31 (5.56) 0.300‡
Potassium, day 1 (mEq/l)
 median (P25-P75) 4.90 (4.40-5.50) 4.90 (4.30-5.50) 4.l80 (4.50-5.60) 0.634§
Calcium, day 2 (mg/dl)
mean (sd) 4.08 (0.62) 4.13 (0.66) 3.89 (0.42) 0.004‡
Magnesium, day 2 (mEq/l)
median (P25-P75) 1.60 (1.50-1.80) 1.60 (1.50-1.80) 1.60 (1.50-1.80) 0.532§
Phosphorus, day 2 (mg/l)
mean (sd) 55.96 (13.03) 54.99 (12.92) 59.40 (12.99) 0.045‡
Urea, day 2 (g/l)
median (P25-P75) 0.36 (0.27-0.47) 0.36 (0.26-0.46) 0.39 (0.31-0.49) 0.145§
Creatinine, day 2 (mg/l)
mean (sd) 10.04 (2.31) 10.21 (2.20) 9.45 (2.61) 0.052‡
Osmolality, day 2 (mOsm/l)
median (P25-P75) 296 (289-305) 296 (289-305) 296 (289-302) 0.759§
Hematocrit, day 1 (%)
mean (sd) 47.60 (6.98) 48.30 (6.93) 45.13 (6.69) 0.007‡
Diuresis, day 1 (ml/kg/hour)
median (P25-P75) 4.30 (3.50-5.60) 4.30 (3.50-5.50) 4.30 (3.30-6.20) 0.685§
sd, standard deviation; P, percentile; § Mann-Whitney U test; ‡ Student’s t-test.
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Table 5 - Multivariate model of the generalized estimation equation (GEE) of the longitudinal variation (from the first or 
second day of life to the seventh) of total fluids, glucose, electrolytes, urea, creatinine, osmolality, hematocrit, diuresis and 
weight adjusted to gestational age, daily variation, BPD and clinical intervention (when indicated).
Independent variables
Constant Gestational age (weeks) Daily variation
(from day 1 or 2 to day 7)
BPD present
Dependent variable β1 CI 95% β2 CI 95% β3 CI 95% β4 CI 95%
Total fluids, (ml/kg/day) 77.444 58.779; 96.109 -0.310 -0.949; 0.329 12.588 12.269; 12.907 1.241 -1.700; 4.181
Glucose, (mg/dl) 185.897 147.841; 223.953 -3.040 -4.329; -1.751 -1.652 -2.540; -0.760 5.249 -1.662; 12,160
Sodium, (mEq/L) 120.817 100.196; 141.437 0.019 -0.187; 0.224 -0.470 -0.667; -0.274 -0.366 -1.501; 0.769
Chloride, (mEq/L) 88.994 66.759; 111.229 0.003 -0.286; 0.291 -0.403 -0.602; -0.205 -0.650 -1.948; 0.648
Potassium, (mEq/L) 5.731 4.582; 6.881 -0.034 -0.068; 0.000 0.013 -0.023; 0.049 0.267 -0.138; 0.673
Calcium, (mg/dl) 1.215 0.378; 2.051 0.089 0.061; 0.117 0.132 0.110; 0.153 -0.044 -0.173; 0.084
Magnesium, (mEq/L) 2.921 2.105; 3.737 -0.028 -0.048; -0.007 -0.040 -0.109; 0.030 -0.029 -0.152; 0.095
Phosphorus, (mg/L) 112.149 88.130; 136.169 -1.551 -2.332; -0.770 -4.520 -7.318; -1.722 4.098 -2.130; 10.325
Urea, (g/L) 1.841 1.553; 2.129 -0.052 -0.062; -0.042 0.007 -0.001; 0.015 -0.003 -0.055; 0.048
Creatinine, (mg/L) 16.114 12.840; 19.388 -0.179 -0.290; -0.069 -0.396 -0.482; -0.310 -0.993 -2.037; 0.052
Osmolality, (mOsm/L) 359.384 341.403; 377.365 -2.039 -2.655; -1.423 -0.687 -1.198; -0.176 -0.333 -3.328; 2.663
Hematocrit, (%) 4.655 -5.598; 14.908 1.588 1.232; 1.944 -0.943 -1.101; -0.784 0.729 -0.811; 2.270
Diuresis, (ml/kg/hour) 7.182 5.581; 8.783 -0.121 -0.176; -0.067 0.183 0.152; 0.214 -0.050 -0.331; 0.231
Weight, (g) -567.33 -906.782; -227.888 55.239 43.187; 67.292 -18.539 -20.312; -16.767 -40.312 -92.488; 11.863
β1, the initial value of the evaluated parameter in the GEE model; β2, the coefficient of gestational age in the GEE model; β3, the coefficient of daily 
variation of the analyzed parameter in the GEE model; β4, the coefficient of BPD in the GEE model; BPD, bronchopulmonary dysplasia; CI, confidence 
interval. Significant CIs are in bold
Table 6 - Multivariate model of the generalized estimation equation (GEE) of the longitudinal variation (from the first or 
second day of life to the seventh) of glucose, sodium, chloride, potassium, calcium, magnesium, phosphorus, creatinine and 
hematocrit adjusted to gestational age, daily variation, BPD and clinical intervention (when indicated).
Independent variables
Values on the first day of life Clinical intervention Interaction between days and 
BPD
Interaction between days and 
intervention
Dependent variable β5 CI 95% β6 CI 95% β7 CI 95% β8 CI 95%
Glucose, (mg/dl) - - 0.363 (1) -1.248; 1.973 - - - -
Sodium, (mEq/l) 0.144 0.000; 0.288 -2.630 (2) -5.933; 0.672 - - - -
Chloride, (mEq/l) 0.193 0.021; 0.364 -1.581 (3) -3.568; 0.406 - - - -
Potassium, (mEq/l) 0.094 0.015; 0.173 -0.250 (4) -0.606; 0.106 -0.087 (5) -0.166; -0.008 - -
Calcium, (mg/dl) - - 0.449 (6) 0.204; 0.694 - - -0.043 7) -0.084; -0.001
Magnesium, (mEq/l) - - -0.417 (8) -0.947; 0.112 0.077 (9) 0.007; 0.147
Phosphorus, (mg/l) - - -11.318 (10) -18.237; -4.399 1.222 (11) -2.373; -0.071 3.873 (12) 1.063; 6.683
Creatinine, (mg/l) - - - - 0.169 (13) 0.000; 0.339 - -
Hematocrit, (%) - - -8.267(14) -10.022; -6.513 - - - -
β5, the coefficient of the serum value of the analyzed parameter on the first or second day of life in the GEE model; β6, the coefficient of the clinical 
intervention (glucose and electrolytes supplementation, and packed red blood cell transfusions) for the analyzed parameters in the GEE model; β7 and β8, 
the coefficients of interaction between two variables in the GEE model; CI, confidence interval; (1) intervention with glucose as continuous variable; (2) 
intervention with sodium (20% NaCl) [0- 2 mEq/Kg/day] (as a reference) vs. [2-8 mEq/Kg/day]; (3) intervention with chloride (20% NaCl) [0- 2 mEq/kg/
day] (as a reference) vs. [2-8 mEq/kg/day]; (4) intervention with potassium (7.5% KCl) [0-1 mEq/kg/day] (as a reference) vs. = 2 mEq/kg/day; (5) interac-
tion between BPD absent * days (as a reference) vs. BPD present * days; (6) intervention with calcium (10% calcium gluconate) [20-30 mg/kg/day] (as 
a reference) vs. [40-60 mg/kg/day]; (7) interaction calcium < 40 mg/kg/day * days (reference) vs. calcium ≥ 40 mg/kg/day * days; (8) intervention with 
magnesium (20% magnesium sulfate) [0.0- 0.3 mEq/kg/day] (as a reference) vs. [0.3- 0.6 mEq/kg/day]; (9) interaction with magnesium [0.0-0.3 ml/kg/
day] * days (as a reference) vs. magnesium [0.3-0.6 ml/kg/day] * days; (10) intervention with phosphate [0-1 mmol/kg/day] (as a reference) vs. [1-2 mmol/
kg/day]; (11) BPD absent * days (as a reference) vs. BPD present * days; (12) phosphorus [0-1 mmol/kg/day] * days (as a reference) vs. phosphorus [1-2 
mmol/kg/day] * days; (13) BPD absent * days (as a reference) vs. BPD present * days; * interaction between two variables; significant CI values are in 
bold; (14) no packed red blood cells transfusion (as a reference) vs. packed red blood cells transfusion
The clinical practice (or intervention) of providing a 
transfusion of packed red blood cells during the first week of 
life was significant in both BPD and non-BPD neonates (β6, 
Table 6). The rate of transfusions in non-BPD patients was 
35% (56/160) vs. 77.7% (35/45) in BPD patients. However, 
there was no interaction between transfusions and BPD in 
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             BPD, bronchopulmonary dysplasia; Ca++, calcium; Cl-, chloride; K+, potassium; Mg++, magnesium; Na+, sodium; P+, phosphorus.
Figure 1 - Graphical representation of the longitudinal variation (first week of life) of the studied parameters in BPD and non-BPD neonates.
the GEE model. Thus, there is no association between the 
number of packed red blood cells transfusions and BPD.
Figure 1 graphically shows the longitudinal variation 
(from the first to the seventh day of life) of the studied 
parameters in BPD and non-BPD neonates.
Parameters of renal function
The association between parameters of renal function 
on the seventh day of life and BPD is reported in Table 
7. Serum creatinine values were not statistically different 
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between BPD and non-BPD patients. Although the serum 
values of creatinine were not significantly different between 
BPD and non-BPD neonates, the GEE model demonstrated 
that the variation of the creatinine values from day 2 to day 
7 of life was associated with the development of BPD (β7, 
Table 6). The serum level of urea was significantly higher 
and the serum level of potassium was significantly lower in 
BPD patients compared to non-BPD patients.
Patent ductus arteriosus
Clinically significant patent ductus arteriosus presented 
a significant association with BPD (Table 2). We found no 
association between the variation of daily total fluid intake 
during the first week of life and patent ductus arteriosus (p = 
0.960, Table 8). The daily total fluid increase did not show a 
significant change with gestational age (p = 0.221). We also 
did not find an association between weight variation during 
the first week of life and patent ductus arteriosus (p = 0.831, 
Table 9). 
Higher mean plasma calcium and lower mean urea 
values during the first week of life were associated with the 
spontaneous closure of ductus arteriosus (Table 10). 
Indomethacin was used significantly more frequently 
during the first week of life for patent ductus arteriosus 
closure in BPD patients than in non-BPD patients (Table 11). 
Table 7 - Comparison of renal function parameters on the seventh day of life between BPD and non-BPD patients. 
Total
(n=205)
BPD absent
(n=160, 78%)
BPD present
(n=45, 22%) p
Creatinine, mean (sd) 8.26 (2.10) 8.20 (2.04) 8.46 (2.30) 0.457‡
Urea, median (P25-P75) 0.34 (0.19-0.60) 0.33 (0.18-0.57) 0.42 (0.30-0.72) 0.019§
Potassium, mean (sd) 4.98 (0.84) 5.07 (0.81) 4.68 (0.88) 0.006‡
sd, standard deviation; P, percentile; ‡ Student’s t-test; § Mann-Whitney test.
Table 8 - Generalized estimation equation (GEE) model to 
assess the association between total fluid intake during the 
first week of life and patent ductus arteriosus.
β CI 95% p
Patent ductus arteriosus
Absent - -
Present 0.068 -2.548 2.684 0.960
Gestational age (weeks) -0.405 -1.053 0.243 0.221
Days 12.588 12.269 12.907 <0.001
Constant 80.405 61.346 99.464 <0.001
CI, confidence interval; dependent variable: total fluid intake; independent 
variables: days, patent ductus arteriosus, gestational age (weeks) and without 
interactions.
Table 9 - Generalized estimation equation (GEE) model to 
assess the association between weight loss during the first 
week of life and patent ductus arteriosus.
β CI 95% P
Patent ductus arteriosus
Absent - -
Present 4.881 -39.939 49.702 0.831
Gestational age (weeks) 58.932 47.033 70.831 <0.001
Days -18.539 -20.312 -16.767 <0.001
Constant -682.870 -1019.851 -345.888 <0.001
CI, confidence interval; dependent variable: weight; independent variables: 
days, patent ductus arteriosus, gestational age (weeks) and without interac-
tion.
Table 10 - Association between mean values of fluids, electrolytes, urea, creatinine and osmolality during the first week of 
life and patent ductus arteriosus.
Total
n=205
PDA absent
n=149 (73%)
PDA present
n=56 (27%) p
Fluids, median (P25-P75) 119.57 (114.29-125.00) 119.29 (114.29-124,57) 120.36 (115.71-126.07) 0.491§
Sodium, mean (sd) 139.08 (2.59) 139.19 (2.48) 138.81 (2.85) 0.351‡
Potassium, mean (sd) 4.95 (0.42) 4.92 (0.43) 5.02 (0.39) 0.135‡
Chloride, mean (sd) 108.12 (3.03) 108.23 (3.16) 107.83 (2.68) 0.407‡
Phosphorus, mean (sd) 53.33 (11.57) 53.06 (12.16) 54.07 (9.89) 0.579‡
Calcium, mean (sd) 4.38 (0.46) 4.47 (0.46) 4.16 (0.39) <0.001‡
Magnesium, median (P25-P75) 1.83 (1.70-2.03) 1.85 1.70-2.01) 1.82 (1.72-2.11) 0.877 §
Urea, median (P25-P75) 0.38 (0.27-0.51) 0.36 (0.25-0.48) 0.47 (0.35-0.55) <0.001§
Creatinine,  mean (sd) 9.16 (1.61) 9.10 (1.56) 9.32 (1.73) 0.388 ‡
Osmolality, mean (P25-P75) 298.17 (291.83-303.67) 296.50 (290.50-302.50) 300.42 (292.75-304.50) 0.091§
P, percentile; sd, standard deviation; ‡ Student’s t-test; § Mann-Whitney test.
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DISCUSSION
The first week of life is a critical transition period for 
very low birth weight neonates. During this time, fluid and 
electrolyte imbalances may be harmful to various organs 
and systems, including the lung, which is usually affected 
by a membrane hyaline disease and other noxious events 
related to mechanical ventilation, inflammation and a left-
to-right shunt from a patent ductus arteriosus. All of these 
noxious events are recognized as risk factors for developing 
DBP. However, little is known about fluid and electrolyte 
imbalances as direct or indirect risk factors for BPD. 
In this study, we found an association between BPD 
and low birth weight, young gestational age, male gender, 
less antenatal steroids use, respiratory distress syndrome 
and patent ductus arteriosus, which are already known 
risk factors. Additionally, the variation in plasma values of 
potassium, phosphorus and creatinine (β7, Table 6) during 
the first week of life was associated with BPD. Serum 
potassium presented an increasing trend during the first 4 
days of life, followed by a decrease in neonates with BPD 
compared to non-BPD neonates, even though the clinical 
intervention (supplementation with potassium) was not 
different between the two groups. Phosphorus presented a 
more rapidly decreasing trend during the first week of life in 
BPD patients. Serum creatinine values presented a sustained 
increase over the first 4 days of life in BPD patients, 
subsequently followed by a decrease, when compared to 
non-BPD newborns. Creatinine and potassium showed a 
similar pattern, with an increase in the first 4 days of life 
followed by a decrease. 
In the first weeks after birth, serum creatinine decreases, 
initially exponentially as the maternally derived creatinine 
load is excreted and then more gradually.21 A single 
measurement of serum creatinine provides no more than a 
crude estimation of renal function, and observing the change 
over time is more informative. A useful clinical indicator 
of renal insufficiency is the failure to observe the expected 
postnatal decline in serum creatinine. Therefore, the change in 
serum creatinine should be considered instead of the absolute 
level. Initially high, the neonatal serum creatinine level 
decreases during the first week. A sustained increase or failure 
to decrease is indicative of a reduction in the glomerular 
filtration rate. The blood urea concentration is of little value 
because it is influenced by numerous non-renal factors.22
The body potassium content is a reflection of the balance 
between its intake and output. Potassium output occurs 
through three primary routes: urine, the gastrointestinal 
tract, and skin. The kidney is the major excretory organ and 
is primarily responsible for regulating the external potassium 
balance.23 A negative potassium balance may be relatively 
common in neonates receiving intensive care.22 In this study, 
the neonates who developed BPD were those who received 
more intensive care with a higher rate of respiratory distress 
syndrome and mechanical ventilation, and this association 
may explain the greater renal losses of both potassium and 
creatinine after day 4 of life. 
The kidney regulates the phosphorus balance, which is 
determined by intrarenal mechanisms and hormonal actions 
on the nephron.24 Parathormone, which is secreted in response 
to low plasma calcium, decreases the resorption of phosphate, 
thus increasing urinary phosphate. In this study, although the 
variation is serum calcium during the first 7 days of life was 
not different between BPD and non-BPD patients, the medium 
serum levels of calcium in BPD neonates were lower than 
those observed in non-BPD patients and were similar to the 
values in neonates who presented a patent ductus arteriosus. 
Although levels of parathormone were not assessed in this 
study, we speculate that BPD patients may have a higher 
production of parathormone, and there may be an association 
between the development of BPD, the calcium-phosphorus 
balance and parathormone regulation. 
There are some problem areas in achieving fluid and 
electrolyte balance in very low and extremely low birth 
weight preterm newborns. One of these problems is poor 
epidermal barrier function. Thin, gelatinous skin promotes 
rapid transcutaneous evaporation, producing severe electrolyte 
disturbances during the first few days of life. After the first 
week of life, however, the risk of dehydration diminishes 
as the skin barrier matures. A second area of major concern 
is pulmonary edema. Fluid replenishment may result in 
increased lung water and contribute to the pathogenesis of 
BPD.23,25-30 Moreover, high fluid intake, which is associated 
with the development of clinically significant patent ductus 
arteriosus and congestive heart failure,28,29 may also contribute 
to the pathogenesis of BPD.30 Perhaps the root of this 
Table 11 - Indomethacin use during the first week of life for patent ductus arteriosus treatment in BPD and non-BPD neonates.
Total
n=205
BPD absent
n=149
BPD present
n=56 p
Indomethacin use, n (%)
No 151 (83) 131 (88) 20 (61) <0.001*
Yes 31 (17) 18 (12) 13 (39)
BPD – bronchopulmonary dysplasia; * Chi-squared test.
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problem is the premature infant’s markedly immature renal 
development, with a small glomerular surface available for 
filtering any fluid volume or salt excess.23
The results of this study support the idea of clinically 
significant patent ductus arteriosus being a risk factor for 
BPD but do not support the idea of an association between 
increased fluid intake or a reduced weight loss and patent 
ductus arteriosus. An association between a lesser or delayed 
diuresis and BPD were also not supported.
Antenatal steroid treatment is associated with lower 
estimated insensible water loss, a decreased incidence of 
hypernatremia (>150 mmol/L sodium) and earlier diuresis 
and natriuresis in extremely low birth weight neonates. An 
explanation is that antenatal steroid causes these changes 
by enhancing epithelial cell maturation and thus improving 
skin barrier function. Antenatal steroid treatment may 
also enhance lung Na+, K+-ATPase activity, leading to an 
earlier postnatal reabsorption of fetal lung fluid, which 
increases extracellular volume expansion and helps prevent 
hypernatremia.31Antenatal steroids also increase renal cell 
differentiation and maturation of the renal autoregulatory 
mechanisms, resulting in an increase in the tubular excretory 
capacity to handle excess solutes.32 Thus, the kidney 
responds to the increased extracellular space by increasing 
sodium excretion, leading to earlier natriuresis and lowering 
the extracellular fluid volume.33 Once a normal extracellular 
space is achieved, renal sodium excretion decreases. 
Maturation of this response would result in a less negative 
sodium balance. Conversely, an up-regulation of tubular 
Na+,K+-ATPase expression, which would lead to renal 
tubular function and increased renal sodium reabsorption, 
may also contribute to this less negative sodium balance.34 
Here, we verified that BPD patients benefited less from 
antenatal steroids use. Also, they presented a slightly 
higher diuresis after the first 24 h of life and slightly 
lower serum levels of sodium during the first 4 days of 
life when compared to non-BPD patients. This is caused 
by higher renal water loss and lower renal reabsorption 
of sodium, which may be related to the more immature 
renal mechanisms that are associated with a reduced use of 
antenatal steroids. The slightly lower serum sodium values 
observed in the first 4 days of life in BPD patients, followed 
by a slight increase (similar to the values observed in the 
non-BPD patients), and the associated decrease in creatinine 
after day 4 of life are suggestive of a delayed maturation 
in the renal handling of sodium. However, according to 
the statistical GEE model used in this study, no significant 
differences were observed in the variation trend of total 
daily fluids, serum sodium and chloride between BPD and 
non-BPD neonates. Also, the decreasing weight pattern was 
similar in both groups. 
With advancing postnatal age, significant improvement 
occurs in renal sodium conservation.35,36 Lorenz et al.37 
identified three distinct phases of fluid and electrolyte 
homeostasis in low birth weight infants with and without 
respiratory distress syndrome during the first days of life. 
The low urine output of the first day (pre-diuretic phase) is 
followed by spontaneous diuresis and natriuresis during the 
second and third days, independent of fluid intake (diuretic 
phase). The onset, duration, and extent of diuresis appear 
to vary. The high rate of urine flow and sodium excretion is 
assumed to be the result of abrupt increases in glomerular 
filtration rate and fractional sodium excretion subsequent 
to the reabsorption of residual lung fluid and expansion 
of extracellular space. During the post-diuretic phase, the 
glomerular filtration rate remains unchanged, and urine 
flow and sodium excretion decrease to values between those 
observed in the pre-diuretic and diuretic phases and begin to 
vary appropriately in response to changes in fluid intake.37,38
Though not significantly associated with BPD, the 
variation of diuresis, serum urea, glucose and osmolality 
presented the same trend. Higher values of diuresis, serum 
urea, and glucose may explain the higher osmolality 
observed during the first week in BPD patients. This higher 
diuresis may be related to renal water loss caused by a more 
immature kidney. 
Although with slightly lower values, the hematocrit 
variation of BPD patients was not associated with the 
development of lung disease in the mathematical GEE model 
used in this analysis.
Caddell6 reviewed the evidence for a role of magnesium 
deficiency in the pathogenesis of BPD. Magnesium 
deficiency increases the susceptibility of cells and tissues to 
peroxidation, worsens the inflammatory reaction, reduces 
the immune response, exaggerates catecholamine release 
in stress, and diminishes energy metabolism. Stigson 
and Kjellmer7 analyzed the absolute levels and normal 
variations of magnesium concentration in cord blood and 
during the first 3 weeks after birth for 69 infants born before 
32 gestational weeks of age. Their results showed that 
during the first week of life, higher values of magnesium 
are associated to a lower rate of PDA closure, for every 
patient. Higher levels of serum magnesium at birth within 
normal variations were associated with a delayed closure 
of the ductus arteriosus and mild but not severe peri- and 
intraventricular hemorrhage. Magnesium is a natural calcium 
channel blocker that inhibits vasoconstriction in numerous 
vascular beds and may be associated with a delayed closure 
of the ductus arteriosus. 
In this study, magnesium plasma values were in the 
normal range in both BPD and non-BPD neonates, as well 
as in neonates with and without patent ductus arteriosus. 
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An association between magnesium levels, patent ductus 
arteriosus and BPD could not be established.
Possibly because of the danger of magnesium toxicity 
and the difficulty in studying preterm extremely low 
birth weight neonates, little is known about magnesium 
supplementation in this group.
Our results demonstrated significantly lower mean 
calcium plasma levels in patients with patent ductus 
arteriosus, suggesting that calcium may have a role in 
ductus closure. The role of calcium sensitization during 
the normoxic contraction of the ductus arteriosus has been 
emphasized in some studies.39, 42 A significantly higher mean 
plasma urea level was also observed during the first week of 
life in patients with patent ductus arteriosus, which is likely 
related to the increased rate of indomethacin use for patent 
ductus arteriosus closure.43
There are some limitations in this study. First, this is a 
retrospective study, and although the methods of fluid and 
electrolyte supplies were the same during the study period, 
the conditions were not exactly the same for all patients. A 
second limitation is the small number (n = 45) of patients 
with BPD (oxygen dependency at 36 weeks gestational age). 
Third, the global severity of the illness may not be entirely 
reflected by the multivariate models used in this study. Aside 
from these limitations, we believe that our results indicate that 
real variations in fluid and electrolyte balance during the first 
week of life may play a role in the pathogenesis of BPD and 
should therefore be considered as risk factors. The scientific 
contribution of this study is the fact that our results should be 
considered as a hypothesis for future studies in the field.
CONCLUSIONS
In this study, the variation in plasma levels of potassium, 
phosphorus and creatinine during the first week of life 
revealed an association with BPD. Although the variation 
in serum calcium was not different between BPD and 
non-BPD patients, the mean serum levels of calcium in 
BPD neonates were lower than those observed in non-BPD 
patients. We speculate that there is an association between 
the development of BPD, calcium-phosphorus balance 
and parathormone regulation during the first week of life, 
especially in neonates who did not benefit from the renal 
maturation effect of antenatal steroids.
Our results also suggest that calcium may have a role in 
ductus arteriosus closure, and the higher mean plasma urea 
values observed in patients with patent ductus arteriosus 
are likely related to an increased rate of indomethacin use. 
Indomethacin may be partially responsible for the variation 
in plasma values of potassium, phosphorus and creatinine 
observed during the first week of life in BPD patients.
All of these issues appear to be interrelated. Indeed, 
despite the multivariate analysis performed, the data 
presented on the evolution of plasma potassium and plasma 
phosphorus during the first week of life and the risk for 
BPD at 36 weeks post-menstrual age may also reflect a bias 
induced by the global severity of the illness, which may not 
be entirely reflected by the multivariate models used in the 
study. Thus, a causative association cannot be established. 
The same lack of causation may be true for the association 
of plasma calcium levels and patent ductus arteriosus, both 
conditions being widely associated with immaturity and 
the severity of disease in premature infants in a number of 
observational studies.
More studies are needed to clarify the role of glomerular 
and tubular function on phosphorus and potassium 
metabolism, the role of parathormone regulation on calcium-
phosphorus equilibrium, and the effects of antenatal steroids, 
lower serum calcium and a patent ductus arteriosus and 
indomethacin on patients who will develop BPD. 
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